No regulatory authority has approved CagriSema yet, so the information here may be updated once an official approval and product label are issued
March 25 Product: AstraZenecas Ultomiris Indication: Neuromyelitis optica spectrum disorder Another rare disease, neuromyelitis optica spectrum disorder (NMOSD), saw a new approval Monday as the FDA greenlit AstraZenecas Ultomiris for patients positive for anti-AQP4 antibodies
The provider matters more than the molecule: sterility, verified concentration, correct dosing, and supervision are what separate a clinical result from a gamble
Y.ShinS
How to use GHK-Cu in a skincare routine GHK-Cu is often compared to other major anti-aging actives
To address this knowledge gap, we have developed a series of genetic models that permit spatiotemporal control over the expression of GCLC, the rate-limiting enzyme in GSH synthesis